INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,970,000 | -16.4% | 3,165,665 | +12.3% | 0.00% | -20.0% |
| Q3 2016 | $26,277,000 | +6.4% | 2,819,426 | +5.5% | 0.01% | 0.0% |
| Q2 2016 | $24,697,000 | +1.1% | 2,672,880 | -4.7% | 0.01% | -16.7% |
| Q1 2016 | $24,429,000 | +31.4% | 2,804,668 | +1.4% | 0.01% | +50.0% |
| Q4 2015 | $18,594,000 | +11.3% | 2,766,936 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $16,703,000 | -27.3% | 2,889,734 | +2.7% | 0.00% | -33.3% |
| Q2 2015 | $22,969,000 | +15.5% | 2,814,851 | +15.5% | 0.01% | +20.0% |
| Q1 2015 | $19,891,000 | -9.1% | 2,437,604 | +2.3% | 0.01% | 0.0% |
| Q4 2014 | $21,881,000 | +54.7% | 2,383,526 | +66.0% | 0.01% | +25.0% |
| Q3 2014 | $14,140,000 | -11.8% | 1,435,523 | -3.2% | 0.00% | -20.0% |
| Q2 2014 | $16,023,000 | – | 1,482,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Investments Management, LLC | 83,277 | $2,244,000 | 0.82% |
| Cedar Brook Financial Partners, LLC | 54,900 | $1,480,000 | 0.66% |
| Coatue Management | 2,750,000 | $74,113,000 | 0.65% |
| Defender Capital, LLC. | 40,251 | $1,084,000 | 0.64% |
| IFG Advisory, LLC | 117,239 | $3,159,000 | 0.57% |
| Harvest Investment Services, LLC | 35,240 | $949,000 | 0.56% |
| Caption Management, LLC | 503,000 | $13,556,000 | 0.45% |
| WASATCH ADVISORS LP | 2,116,427 | $57,038,000 | 0.41% |
| Unified Trust Company, N.A. | 19,716 | $531,000 | 0.40% |
| Strategic Wealth Management Group, LLC | 25,175 | $678,000 | 0.40% |